Insiders MannKind Corporation

Equities

MNKD

US56400P7069

Delayed Nasdaq Other stock markets 20:57:46 14/05/2024 BST			5-day change	1st Jan Change
4.495 ^USD	+1.93%		+0.56%	+23.49%

05-08	Transcript : MannKind Corporation, Q1 2024 Earnings Call, May 08, 2024
05-08	Earnings Flash (MNKD) MANNKIND Posts Q1 EPS $0.05	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MannKind CFO Binder to Retire in April, Names New CFO	03-26	MT
MannKind Corporation Appoints Steven B. Binder as Executive Vice President, Special Projects	03-26	CI
Mannkind Insider Sold Shares Worth $801,928, According to a Recent SEC Filing	12-18	MT
MannKind's German Manufacturing Facility Caught Fire	03/07/23	MT
MannKind Hires Burkhard Blank as CMO	24/05/23	MT
Dr. Burkhard Blank Joins MannKind Corporation as Executive Vice President of Research & Development and Chief Medical Officer	24/05/23	CI
MannKind Appoints Lauren Sabella as COO	27/03/23	MT
Lauren Sabella Joins MannKind Corporation as Executive Vice President, Chief Operating Officer	27/03/23	CI
Mannkind Corporation Announces Resignation of Alejandro Galindo as Executive Vice President – Endocrine Business Unit, Effective October 21, 2022	26/09/22	CI
MannKind Corporation Appoints James S. Shannon as the Chairman of the Board of Directors	10/12/20	CI
MannKind : Sabrina Kay Appointed to MannKind Board of Directors	30/11/20	AQ
MannKind Corporation Appoints Sabrina Kay Ed.D. to Its Board of Directors	30/11/20	CI
MannKind Corporation Announces Resignation of David Kendall as Chief Medical Officer	28/08/20	CI
Mannkind Corporation Appoints Alejandro Galindo as Chief Commercial Officer, Effective August 4, 2020	20/07/20	CI
MannKind Corporation Announces Retirement of Nordhoff from the Audit Committee and Board	10/04/20	CI
Jennifer Grancio Appointed to MannKind Board of Directors	24/03/20	GL
Jennifer Grancio Joins Mannkind's Board of Directors	24/03/20	CI
Mannkind Appoints Tony Hooper to its Board of Directors and Member of the Audit Committee, Effective January 1, 2020	21/11/19	CI
MannKind Appoints Christine Mundkur to its Board of Directors	27/11/18	CI
MannKind Corporation Appoints David M. Kendall as Chief Medical Officer, Effective February 12, 2018	06/02/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders MannKind Corporation

Equities

MNKD

US56400P7069

Insiders

Filters